4//SEC Filing
Forman Mark S 4
Accession 0001415889-24-003637
CIK 0001787297other
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 7:34 PM ET
Size
16.0 KB
Accession
0001415889-24-003637
Insider Transaction Report
Form 4
Forman Mark S
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2024-02-10−5,000→ 10,000 total→ Common Stock (5,000 underlying) - Award
Employee Stock Option (right to buy)
2021-08-16+130,000→ 130,000 totalExercise: $10.84Exp: 2031-08-15→ Common Stock (130,000 underlying) - Award
Restricted Stock Unit
2022-02-10+15,000→ 15,000 total→ Common Stock (15,000 underlying) - Exercise/Conversion
Common Stock
2024-02-10+5,000→ 50,269 total - Sale
Common Stock
2024-02-13$0.97/sh−1,638$1,589→ 48,631 total - Award
Employee Stock Option (right to buy)
2022-02-10+25,000→ 25,000 totalExercise: $4.52Exp: 2032-02-09→ Common Stock (25,000 underlying)
Footnotes (5)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to satisfy tax withholding obligations in connection with the vesting and settlement of RSUs; it does not represent a discretionary trade by the Reporting Person. Pursuant to the Issuer's equity incentive plan, an award recipient's tax withholding obligations must be funded by a "sell to cover" transaction.
- [F3]The stock option vests as to 25% of the total shares on August 16, 2022, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F4]The stock option vests as of 1/48 of the total shares monthly beginning on March 10, 2022 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
- [F5]1/3 of the RSUs will vest on February 10, 2024 and 2/3 of the RSUs will vest on February 10, 2025, subject to the Reporting Person's continued service to the Issuer on each vesting date.
Documents
Issuer
Passage BIO, Inc.
CIK 0001787297
Entity typeother
Related Parties
1- filerCIK 0001922353
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 7:34 PM ET
- Size
- 16.0 KB